The long-term objective of this research is to extend our understanding of the molecular mechanisms involved in the actions of glucocorticoids on their target tissues. Glucocorticoids are widely used in the treatment of cancer and inflammatory diseases and characterizing the mechanisms by which their receptors regulate gene expression constitutes a fundamental problem in molecular pharmacology.
The aims of this proposal focus on determining the role of receptor phosphorylation in glucocorticoid hormone action. The glucocorticoid receptor is a phosphoprotein and we have mutated the cDNA for the mouse receptor at all seven phosphorylation sites. We have analyzed the transcriptional activity of mutant receptors at the mouse mammary tumor virus promoter in transient transfections and we find a significant 22% reduction compared to wild-type receptor activity. In cells stably transfected with mutant receptors, we observe a 40% reduction in receptor activity at this promoter. Additionally, induction of the endogenous glucocorticoid-responsive gene for glutamine synthetase by mutant receptors is reduced by 25%. As the effect of receptor phosphorylation on transactivation may be promoter-specific, we will extend this analysis to other endogenous glucocorticoid- regulated genes and to minimal GRE promoter constructs containing defined sites for other transcriptional factors. The first set of experiments will examine the effect of phosphorylation site mutations on the regulation of the endogenous glucocorticoid- responsive genes for mouse nerve growth factor and sgk. The mRNA for nerve growth factor is reduced and the mRNA for sgk is induced by glucocorticoids. Our studies will also determine if receptor phosphorylation is involved in the down-regulation of receptor mRNA and the turnover of receptor protein. The induction of responsive genes by certain steroid hormones is potentiated by activation of cellular phosphorylation cascades and by stress. A third series of experiments will evaluate the contribution of receptor phosphorylation in coupling extracellular signaling pathways with steroid receptor signal transduction to the nucleus. There is some evidence that receptor phosphorylation may regulate the intracellular trafficking of the glucocorticoid receptor. A fourth set of experiments will determine if phosphorylation modulates receptor recycling and reutilization. A fifth set of experiments will identify the remaining phosphorylation site on the receptor and examine its contribution to receptor activities.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK047951-04
Application #
2634269
Study Section
Endocrinology Study Section (END)
Program Officer
Margolis, Ronald N
Project Start
1995-01-01
Project End
1999-12-31
Budget Start
1998-01-15
Budget End
1999-12-31
Support Year
4
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of South Carolina at Columbia
Department
Pharmacology
Type
Schools of Medicine
DUNS #
111310249
City
Columbia
State
SC
Country
United States
Zip Code
29208
Galigniana, Mario D; Harrell, Jennifer M; Housley, Paul R et al. (2004) Retrograde transport of the glucocorticoid receptor in neurites requires dynamic assembly of complexes with the protein chaperone hsp90 and is linked to the CHIP component of the machinery for proteasomal degradation. Brain Res Mol Brain Res 123:27-36
Wan, Y; Coxe, K K; Thackray, V G et al. (2001) Separable features of the ligand-binding domain determine the differential subcellular localization and ligand-binding specificity of glucocorticoid receptor and progesterone receptor. Mol Endocrinol 15:17-31
Galigniana, M D; Radanyi, C; Renoir, J M et al. (2001) Evidence that the peptidylprolyl isomerase domain of the hsp90-binding immunophilin FKBP52 is involved in both dynein interaction and glucocorticoid receptor movement to the nucleus. J Biol Chem 276:14884-9
Galigniana, M D; Housley, P R; DeFranco, D B et al. (1999) Inhibition of glucocorticoid receptor nucleocytoplasmic shuttling by okadaic acid requires intact cytoskeleton. J Biol Chem 274:16222-7
Wei, P; Ahn, Y I; Housley, P R et al. (1998) Modulation of hormone-dependent glucocorticoid receptor function using a tetracycline-regulated expression system. J Steroid Biochem Mol Biol 64:1-12
Cohen, P (1998) Serum insulin-like growth factor-I levels and prostate cancer risk--interpreting the evidence. J Natl Cancer Inst 90:876-9
Galigniana, M D; Scruggs, J L; Herrington, J et al. (1998) Heat shock protein 90-dependent (geldanamycin-inhibited) movement of the glucocorticoid receptor through the cytoplasm to the nucleus requires intact cytoskeleton. Mol Endocrinol 12:1903-13
Khan, M A; Canhoto, A J; Housley, P R et al. (1997) Glucocorticoids stimulate growth of human papillomavirus type 16 (HPV16)-immortalized human keratinocytes and support HPV16-mediated immortalization without affecting the levels of HPV16 E6/E7 mRNA. Exp Cell Res 236:304-10